DarioHealth Corp.

    Jurisdiction
    United States
    ISIN
    US23725P2092 (DRIO)
    Sectors
    1. Healthcare
    2. Medical - Diagnostics & Research

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    3 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. Read full profile

    Fundamentals

    Net revenue
    €23.16M
    Gross margin
    55.0%
    EBIT
    -€36.69M
    EBIT margin
    -158.5%
    Net income
    -€13.06M
    Net margin
    -56.4%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €32.63M +40.9% -€21.35M +63.4%
    €32.42M -0.6% -€27.43M +28.5%
    €44.29M +36.6% -€27.70M +1.0%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Nelson Steven Charles President and CCO +40K $0.53 +$21.20K

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 118K $72.00K +1.3K Buy

    Earnings Calls

    Latest earnings call: May 15, 2024 (Q1 2024)

    Add to watchlist

    Notifications